Delivery Order SPE2DR25D3014-SPE2DR26FP1JA
- Not listed
- The Defense Logistics Agency awarded a $13,012.76 delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for supply of RINVOQ ER 15 mg tablets in quantities of 30-unit bottles. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of December 2, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of RINVOQ ER 15 mg tablets in quantities of 30 units. This non-competitive, firm fixed-price delivery order carries a ceiling value of $15,435.05 and is scheduled for completion by November 4, 2025. The award represents a continuation of AmerisourceBergen's extensive pharmaceutical supply relationship with the federal government, specifically supporting military and veteran...
- The Defense Logistics Agency awarded a $26,071.80 delivery order to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of RINVOQ ER 15 mg tablets (30-unit bottles). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of November 18, 2025. AmerisourceBergen Drug Corp will perform this order from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 10, 2025, for supply of RINVOQ ER 15 mg tablets (30-count units) under a firm fixed price contract valued at $11,902.23. This is a non-set-aside competitive award with an ultimate completion date of December 11, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of RINVOQ ER 15 mg tablets in quantities of 30 units. This competitively awarded, firm fixed-price delivery order has a ceiling value of $87,963.69 and an ultimate completion date of December 10, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency awarded a $6,558.42 firm fixed-price delivery order to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) on December 8, 2025, with completion targeted for December 9, 2025. This non-competitive delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The work will be performed at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of RINVOQ ER 15mg tablets (30-count package) under a firm fixed-price contract. The award, valued at $3,279.21, represents a non-set-aside competitive award and is scheduled for completion by December 8, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of RINVOQ ER 15 mg tablets in a quantity of 30 units. The contract is valued at $155,311.70 and utilizes firm fixed price terms, with an ultimate completion date of December 2, 2025. This is an unset-aside, competitively awarded delivery order, indicating that AmerisourceBergen competed against other qualified vendors to secure this pharmaceutical supply requirement. The place...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of RINVOQ ER 15 mg tablets (30-count unit of use packaging) under a firm fixed-price contract valued at $60,356.04, with completion scheduled for September 17, 2025. This non-set-aside competitive award leverages AmerisourceBergen's position as a major pharmaceutical distributor and represents a continuation of the company's extensive support to federal medical...
- The Defense Logistics Agency awarded a $15,876.35 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of RINVOQ ER 15 mg tablets (30-count units). This firm fixed price contract, with an ultimate completion date of July 21, 2025, represents a non-competitive delivery against AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- SPE2DR25D3014Indefinite Delivery Contract
- SPE2DR25D3014-SPE2DR26FP1JADelivery Order
The Defense Logistics Agency awarded a $5,057.46 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 15, 2025, for the supply of RINVOQ ER 15 mg tablets (30-count units). This competitively awarded, non-set-aside contract is scheduled for completion by December 16, 2025, with performance at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's existing contract vehicle with the DLA. This award is issued under AmerisourceBergen's Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical federal medical vendor, AmerisourceBergen supplies a broad portfolio of pharmaceutical products and medical supplies to support military and veteran healthcare systems. The company's extensive federal contract history demonstrates consistent capability in delivering diverse pharmaceutical commodities through firm fixed-price delivery orders across multiple therapeutic domains, positioning it as a primary supplier for Department of Defense medical procurement requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.1k | 12/14/25 |